← All trials
NCT03312205
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 29, 2017
- Primary completion
- Aug 29, 2019
- Completion date
- Aug 29, 2023
- First posted
- Oct 17, 2017
- Last posted
- Jan 9, 2019
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hebei Senlang Biotechnology Inc., Ltd.Lead sponsor
- Ludaopei HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.